Clinical Trials Directory

Trials / Completed

CompletedNCT06469359

Analyzes of Nasal Tissue-resident Memory Immune Cells and Peripheral Memory Cells Able to Migrate to Airway Tissues (MUCOVAC)

Development of a Methodology to Analyze Nasal Tissue-resident Memory Immune Cells and Peripheral Memory Cells Able to Migrate to Airway Tissues (MUCOVAC)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Clinical evaluation of vaccines against respiratory viruses is currently based on the analysis of systemic immune responses, whereas respiratory immunity is the first line of defense against respiratory pathogens. In addition to secretory immunoglobulin A (IgA) in mucosal fluids which are essential to neutralize the pathogens at mucosal surfaces, tissue-resident memory immune cells have been shown to be crucial in protection. Furthermore, memory immune cells in blood able to migrate to airway tissues also play a crucial role. Airway immune responses have not been studied a lot due to the lack of a standardized methodology to evaluate them in humans.

Detailed description

The goal of this study is to develop a methodology to collect and analyze nasal tissue-resident memory T and B cells and to evaluate peripheral memory T and B cells expressing airway homing markers in healthy volunteers. Three devices for nasal cell sampling will be compared. Tissue-resident and peripheral memory immune responses will be determined using flow cytometry and correlated with humoral and cellular responses, as well as with gene expression at mucosal and systemic levels. .

Conditions

Interventions

TypeNameDescription
DEVICENasal tissue-resident memory T and B cellsNasal tissue-resident memory T and B cells are quantified using flow cytometry.
DEVICENasal fluid samplingNasal fluid is collected using strip (Hunt Development) in both nostrils
DEVICESaliva samplingSaliva is collected using Oracol (Malvern Medical Developments)
OTHERBlood samplingIsolation of peripheral blood mononuclear cells (PBMC) and serum from blood
DIAGNOSTIC_TESTELISAELISA to measure antibody responses in mucosal fluids and blood
DIAGNOSTIC_TESTNeutralization testNeutralization test to measure neutralizing antibody responses in mucosal fluids and blood to measure neutralizing antibody responses in mucosal fluids and blood
DIAGNOSTIC_TESTELISPotELISPot to measure cellular responses in blood
DIAGNOSTIC_TESTTranscriptomicsTranscriptomics to quantify the gene expression of immunological markers in blood

Timeline

Start date
2024-07-22
Primary completion
2024-11-11
Completion
2024-11-11
First posted
2024-06-21
Last updated
2024-12-18

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06469359. Inclusion in this directory is not an endorsement.